Hologic (NASDAQ:HOLX) Reports Q4 In Line With Expectations But Full-Year Sales Guidance Misses Expectations
Medical technology company Hologic (NASDAQ:HOLX) met Wall Street’s revenue expectations in Q4 CY2024, but sales were flat year on year at $1.02 billion. On the other hand, next quart...
FormFactor (NASDAQ:FORM) Reports Q4 In Line With Expectations But Stock Drops 21.5%
Semiconductor testing company FormFactor (NASDAQ:FORM) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 12.7% year on year to $189.5 million. On the other hand, nex...
PTC’s (NASDAQ:PTC) Q4 Sales Top Estimates But Full-Year Sales Guidance Misses Expectations Significantly
Engineering and design software provider PTC (NASDAQ:PTC) reported Q4 CY2024 results beating Wall Street’s revenue expectations , with sales up 2.7% year on year to $565.1 million. O...
